Fifth Third Wealth Advisors 13F: Adds $848K to Zoetis (ZTS) Stake
Key Points
- Fifth Third Wealth Advisors expanded its Zoetis Inc. ZTS holdings by 32.2% to 49,817 shares, valued at about $3.5 million.
- Zoetis trades around $81.00, well below its 52-week high of $147.93 as investors weigh the company's valuation and trailing revenue of $9.53 billion.
- Other institutional managers adjusted their positions in ZTS, while analysts maintain a consensus buy rating with a mean price target of $93.00.
Get Zoetis text alerts
We text you when insiders, Congress, analysts or big funds move on $ZTS.
By entering your mobile number and tapping the sign-up button, you provide express written consent to receive recurring automated text messages from TradeTexts at that number, including stock alerts about SEC filings, insider and congress trades, analyst ratings, hedge fund moves, and earnings results. Consent is not a condition of any purchase. Message frequency varies. Messages are not investment advice. Message and data rates may apply. Reply HELP for help and STOP to opt out at any time. See our Terms and Privacy Policy.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Zoetis Inc. alert may contain errors. Disclosures
Fifth Third Wealth Advisors lifted its stake in Zoetis Inc. ZTS by 32.2% during the quarter, adding 12,137 shares to bring its total investment to 49,817 shares. According to a Form 13F filing filed with the SEC on October 22, 2026, the value of the firm's position reached $3,478,751.
ZTS
Zoetis Inc.
Fifth Third Wealth Advisors vs. the S&P 500
Hypothetical returns from Fifth Third Wealth Advisors's disclosed trades, not real profit or advice. How we model this.
What Changed in Fifth Third Wealth Advisors's Zoetis Inc. Position
The adjustment expands the firm's exposure to the animal health company from its previous level of 37,680 shares. Zoetis shares closed at $82.00 on the October 22 filing date.
Other Institutional Activity in Zoetis Inc.
Other institutional managers also adjusted their positions in Zoetis Inc. Moran Wealth Management grew its holdings by 35,213 shares, ending with 445,975 shares worth about $31,142,424. Fideuram - Intesa Sanpaolo Private Banking S.P.A. grew its holdings by 101,852 shares, ending with 265,022 shares worth about $18,506,492. Midwest Trust reduced its holdings by 114,689 shares, ending with 9,372 shares worth about $654,447. Quilter reduced its holdings by 80,776 shares, ending with 79,714 shares worth about $5,566,429. Guyasuta Investment Advisors reduced its holdings by 4,210 shares, ending with 0 shares worth about $0.
Zoetis Inc. Stock Up 1.7%
Zoetis recently traded around $81.00 as of October 24, down about 1.2% since the filing date. The stock sits below its 52-week high of $147.93 and above its 52-week low of $68.77.
Recent Earnings
Zoetis reported trailing twelve-month revenue of $9.53 billion alongside earnings of $6.26 per share. The company maintains a net profit margin of 27.7% and a return on equity of 64.9%, with its next earnings report scheduled for November 5, 2026.
Dividend
Zoetis pays an annual dividend rate of $2.12 per share.
Insider Buying and Selling at Zoetis Inc.
Company insiders executed open market transactions prior to the filing, including purchases by directors Michael B. McCallister, Frank A. Amelio, and Paul M. Bisaro.
Analysts Set New Price Targets
Wall street research firms adjusted their outlooks on the stock ahead of the filing. Citigroup, Stifel, TD Cowen, Goldman Sachs, and Jefferies issued ratings and price updates through the summer and autumn.
About Zoetis Inc.
Zoetis Inc. discovers, develops, and manufactures medicines, vaccines, and diagnostic products for livestock and companion animals worldwide. The company operates from its headquarters in Parsippany, New Jersey.
Bottom Line
Institutional investors continue to recalibrate their portfolios in Zoetis ahead of the company's upcoming earnings release on November 5, 2026. Observers will monitor how valuation shifts align with ongoing analyst price targets.
Related Filing Alerts
Source: Fifth Third Wealth Advisors's 13F filing on $ZTS (Oct 22, 2026). 13F filings show holdings as of the end of the reporting quarter and may not reflect the fund's current position. Written by software, not financial advice. How we make alerts